Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.44 |
| ▸ | NQO2 | P16083 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ERN1 | O75460 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12141429 | 0.87 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL4694851 | 0.85 | CRHR1 (0.46) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL15434479 | 0.84 | CALM1 (0.49) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL8066434 | 0.83 | ALDH1A1 (0.44) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL8256668 | 0.83 | TAAR1 (0.45) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL30277943 | 0.83 | CYP3A4 (0.74) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL3300408 | 0.83 | CYP3A4 (0.74) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL9349720 | 0.83 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL13696428 | 0.83 | ALDH1A1 (0.45) | ALDH1A1CYP3A4CA12CA1CA2 | |
| SCHEMBL28612479 | 0.82 | CYP3A4 (0.39) | ALDH1A1CYP3A4CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119595807-A | Method for measuring impurity content in phloroglucinol trimethyl ether | 康普药业股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-3276696-B1 | FUNCTIONAL LAYER FORMING COMPOSITION AND METHOD FOR MANUFACTURING THE SAME | SEIKO EPSON CORP (JP) | 2023-10-11 | — | — | EP | claimed |
| CN-113122393-A | Extraction, purification and detection method of acanthaceae volatile oil and application thereof | 山东大学 | 2021-07-16 | — | — | CN | claimed |
| CN-105431425-B | Compound, material for organic electroluminescent element, ink composition, organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2019-10-01 | — | — | CN | claimed |
| US-10079342-B2 | Functional layer forming composition, method for producing functional layer forming composition, method for producing organic EL element, organic EL device, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2018-09-18 | — | — | US | claimed |
| CN-107980775-A | It is a kind of to utilize method of the bamboo vinegar extraction with disease-preventing and yield-increasing functional preparation | 郑州依侬生物科技有限公司 | 2018-05-04 | — | — | CN | claimed |
| US-20180062078-A1 | FUNCTIONAL LAYER FORMING COMPOSITION, METHOD FOR PRODUCING FUNCTIONAL LAYER FORMING COMPOSITION, METHOD FOR PRODUCING ORGANIC EL ELEMENT, ORGANIC EL DEVICE, AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2018-03-01 | — | — | US | claimed |
| EP-3276696-A1 | FUNCTIONAL LAYER FORMING COMPOSITION, METHOD FOR MANUFACTURING FUNCTIONAL LAYER FORMING COMPOSITION, METHOD FOR MANUFACTURING ORGANIC EL ELEMENT, ORGANIC EL DEVICE, AND ELECTRONIC EQUIPMENT | Seiko Epson Corporation (JP) | 2018-01-31 | — | — | EP | claimed |
| CN-107431137-A | Functional layer formation composition and its manufacture method, the manufacture method of organic EL element, organic el device, electronic equipment | 精工爱普生株式会社 | 2017-12-01 | — | — | CN | claimed |
| CN-100422734-C | Detection method for toxicological harmless traditional Chinese herbal Asarum | UNIV SHENYANG PHARMACEUTICAL (CN) | 2008-10-01 | — | — | CN | claimed |
| JP-63027452-A | — | — | None | — | — | JP | disclosed |
| CN-122080034-A | Polycyclic aromatic compound and organic electroluminescent element | — | 2026-05-26 | — | — | CN | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| CN-120157693-A | Polycyclic aromatic compound and organic electroluminescent element | 爱思开新材料捷恩智株式会社 | 2025-06-17 | — | — | CN | disclosed |
| CN-120118107-A | Polycyclic aromatic compound and organic electroluminescent element | 爱思开新材料捷恩智株式会社 | 2025-06-10 | — | — | CN | disclosed |
| US-5136104-A | Catalytic gas phase oxidation of a substituted toluene; high yield | NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) | 1992-08-04 | — | — | US | disclosed |
| EP-0415566-A1 | Heterocyclic compounds, processes for producing them and pharmaceutical compositions comprising them | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0347021-A2 | Process for the preparation of 2,3-dimethoxy-5-methylbenzoquinone | THE STATE OF JAPAN, as Represented by the DIRECTOR GENERAL of the AGENCY of INDUSTRIAL SCIENCE and TECHNOLOGY (JP) | 1989-12-20 | — | — | EP | disclosed |
| JP-S6327452-A | PRODUCTION OF BENZALDEHYDE DERIVATIVE | OTSUKA CHEM CO LTD | 1988-02-05 | — | — | JP | disclosed |
| CN-86100772-A | 2,3-dimethoxy-5-methyl isophthalic acid, 4-benzoquinones synthetic method | — | 1987-01-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | ALDH1A1 3874/4885CYP3A4 2348/4885CA12 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.